Monoclonal Antibody Treatment
What Are Monoclonal Antibodies?
Monoclonal antibodies are among the most promising treatments for mild to moderate COVID-19, the disease caused by the novel coronavirus SARS-CoV-2. Monoclonal antibodies are just like your body's antibodies but selected for their strong ability to resist the virus. They are produced like a medication and help your body fight illness. In 2020, the Food and Drug Administration issued an emergency use authorization to permit monoclonal antibodies as a treatment option for COVID-19.
Who is Eligible for Monoclonal Antibody Treatment?
Anyone who tested positive for COVID-19, has had symptoms for 10 days or less, and one of the following:
- Be at least 65 years old
- Have a BMI of more than 25 kg/m2, or if age 12-17, have BMI above the 85th percentile for their age and gender based on CDC growth charts
- Currently Pregnant
- Have a medical condition, including:
- Chronic kidney disease
- Cardiovascular disease (including congenital heart disease, hypertension)
- Down syndrome
- Liver disease
- Chronic lung disease (ex. COPD)
- Sickle cell disease
- Immunosuppressive disease or immunosuppressive treatment
- History of stroke or cerebrovascular disease
- Current or history of substance abuse
- Neurodevelopmental disorders or other conditions that confer medical complexity
- Have a medical-related technological dependence (e.g., tracheostomy, gastrostomy)
Note: Monoclonal antibody treatment needs to be given within 10 days of the start of symptoms.